WST

218.90

4.20% 8.82

Pre-mercato: 219.36 0.46 +0.21%

West Pharmaceutical Services Inc (WST)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché WST Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$210.08

Aprire:

$211.5

Volume 24 ore:

785.96K

Relative Volume:

1.07

Capitalizzazione di mercato:

$15.73B

Reddito:

$2.90B

Utile/perdita netta:

$467.20M

Rapporto P/E:

34.36

EPS:

6.37

Flusso di cassa netto:

$306.90M

1 W Prestazione:

-0.97%

1M Prestazione:

+1.43%

6M Prestazione:

-37.07%

1 anno Prestazione:

-31.17%

Intervallo 1D:

$211.10

$218.90

Intervallo di 1 settimana:

$206.80

$226.03

Portata 52W:

$187.43

$352.33

West Pharmaceutical Services Inc Stock (WST) Company Profile

Nome

West Pharmaceutical Services Inc

Settore

Healthcare (1161)

Industria

Medical Instruments & Supplies (58)

Telefono

(610) 594-2900

Indirizzo

530 HERMAN O. WEST DRIVE, EXTON, PA

Dipendente

10,600

Cinguettio

@WestPharma

Prossima data di guadagno

2024-10-24

Ultimi documenti SEC

WST's Discussions on Twitter

Confronta WST con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
WST West Pharmaceutical Services Inc	218.90	15.88B	2.90B	467.20M	306.90M	6.37
ISRG Intuitive Surgical Inc	511.00	183.59B	8.71B	2.48B	1.75B	6.82
BDX Becton Dickinson Co	181.28	51.10B	20.87B	1.50B	2.59B	5.24
ALC Alcon Inc	88.66	42.51B	9.93B	1.12B	1.58B	2.25
RMD Resmed Inc	267.40	36.95B	5.02B	1.31B	1.56B	8.91

West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-06-24	Iniziato	Barclays	Equal Weight
2025-03-18	Iniziato	Evercore ISI	Outperform
2025-02-14	Aggiornamento	Deutsche Bank	Hold → Buy
2025-01-08	Iniziato	Citigroup	Buy
2024-12-13	Iniziato	Wolfe Research	Peer Perform
2024-12-12	Aggiornamento	UBS	Neutral → Buy
2024-02-07	Aggiornamento	Jefferies	Hold → Buy
2023-06-16	Aggiornamento	BofA Securities	Neutral → Buy
2023-04-11	Aggiornamento	Stephens	Equal-Weight → Overweight
2022-12-14	Iniziato	Deutsche Bank	Hold
2022-11-30	Iniziato	UBS	Neutral
2022-10-28	Downgrade	BofA Securities	Buy → Neutral
2020-11-10	Iniziato	KeyBanc Capital Markets	Overweight
2020-10-14	Iniziato	Stephens	Equal-Weight
2020-07-21	Aggiornamento	BofA Securities	Neutral → Buy
2020-04-24	Aggiornamento	BofA/Merrill	Underperform → Neutral
2019-12-12	Downgrade	BofA/Merrill	Neutral → Underperform
2019-07-26	Aggiornamento	BofA/Merrill	Underperform → Neutral
2019-05-01	Downgrade	Jefferies	Buy → Hold
2019-04-23	Iniziato	William Blair	Outperform
2018-04-25	Downgrade	BofA/Merrill	Neutral → Underperform
2018-01-24	Iniziato	Goldman	Neutral
2017-10-17	Downgrade	BofA/Merrill	Buy → Neutral
2017-10-03	Iniziato	Stephens	Equal-Weight
2017-09-15	Aggiornamento	Jefferies	Hold → Buy
2016-10-28	Aggiornamento	Wells Fargo	Market Perform → Outperform
2016-09-21	Downgrade	Wells Fargo	Outperform → Market Perform
2016-03-22	Iniziato	Wells Fargo	Outperform
2010-05-14	Reiterato	UBS	Neutral
2010-02-23	Iniziato	Jefferies & Co	Buy
2008-12-19	Iniziato	UBS	Neutral

Mostra tutto

West Pharmaceutical Services Inc Borsa (WST) Ultime notizie

Jul 22, 2025

West Pharmaceutical Services (WST) Q2 Earnings Report Preview: What To Look For - FinancialContent

Jul 22, 2025

West Pharmaceutical Names Robert McMahon as New CFO - AInvest

Jul 22, 2025

What analysts say about West Pharmaceutical Services Inc. stockUnprecedented profit potential - jammulinksnews.com

Jul 22, 2025

WST Q2 Earnings Preview: Will the Stock's Segmental Edge Hold Up? - TradingView

Jul 22, 2025

Barclays Cautious on West Pharma (WST) on Non-Core Weakness and Injectable Disruption Risks - Insider Monkey

Jul 22, 2025

West Pharmaceutical Services Inc. Stock Analysis and ForecastDynamic portfolio growth - jammulinksnews.com

Jul 22, 2025

West Pharmaceutical Services taps Robert McMahon as CFO - MSN

Jul 22, 2025

Jul 21, 2025

Is West Pharmaceutical Services Inc. a good long term investmentPhenomenal wealth increase - Autocar Professional

Jul 21, 2025

What drives West Pharmaceutical Services Inc. stock priceHigh-octane investment gains - Autocar Professional

Jul 21, 2025

West Pharmaceutical Appoints New CFO Robert McMahon - TipRanks

Jul 21, 2025

West pharmaceutical services appoints Robert McMahon as new CFO - Investing.com

Jul 21, 2025

Healthcare Veteran Robert McMahon Exits Agilent to Lead West Pharma's Financial Future - Stock Titan

Jul 21, 2025

West Welcomes Robert McMahon as Incoming Chief Financial Officer - The Malaysian Reserve

Jul 21, 2025

Jul 20, 2025

Mutual of America Capital Management LLC Sells 252 Shares of West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World

Jul 20, 2025

Jul 19, 2025